Inhibition of myosin light-chain phosphorylation inverts the birefringence response of porcine airway smooth muscle.
Muscle birefringence, caused mainly by parallel thick filaments, increases in smooth muscle during stimulation, signalling thick filament formation upon activation. The reverse occurs in skeletal muscle, where a decrease in birefringence has been correlated with crossbridge movement away from the thick filaments. When force generation by trachealis muscle was inhibited with wortmannin, which inhibits myosin light-chain phosphorylation and thick-filament formation, but not the calcium increase caused by stimulation, the birefringence response inverted, suggesting crossbridge movement similar to that of skeletal muscle. Resistance to quick stretches was much greater in stimulated muscle than in unstimulated muscle before wortmannin treatment and no different in stimulated and unstimulated muscle after force inhibition by wortmannin. Before wortmannin treatment, stimulation reduced thick-filament cross-sectional areas in electron micrographs by 44%. After force inhibition by wortmannin, filament areas were not significantly different in stimulated and unstimulated muscle and not significantly different from those of relaxed muscle without wortmannin treatment. These results suggest that myofibrillar-space calcium causes crossbridges to move away from the thick filaments without firmly attaching to thin filaments.
Smolensky
Alexander V
AV
Krannert Institute of Cardiology, Indiana University School of Medicine, 1800 N. Capitol Ave, Indianapolis, IN 46202, USA.
Gilbert
Susan H
SH
Harger-Allen
Margaret
M
Ford
Lincoln E
LE
D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D001718:Birefringence; D002118:Calcium / Q000494:pharmacology; D004558:Electric Stimulation; D066298:In Vitro Techniques; D008854:Microscopy, Electron; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D018994:Myosin Light Chains / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D013552:Swine; D014132:Trachea / Q000502:physiology*; D000077191:Wortmannin
D000730:Androstadienes; D018994:Myosin Light Chains; D047428:Protein Kinase Inhibitors; D002118:Calcium; D000077191:Wortmannin